Monitoring global health

Problems are primarily national
Editor-Murray et al urge for improved global reporting of health data.
1 They also highlight the difficulty of showing national decision makers that good health data can strongly support decision making. Why is this?
A reason may be that data are always subject to interpretation. The article by Murray et al is a case in point. They want to establish "an independent monitoring organisation," arguing that the World Health Organization is not fit to undertake the job because of tension between advocacy, monitoring, and evaluation. But evidence that it is this tension that leads to poor monitoring by WHO is weak, at best.
In reality, the problems of global health reporting are primarily national (and subnational). The fact that the sum of deaths claimed by different programmes is greater than the actual number of deaths reflects epidemiological methods and the current limitations in global health reporting, more than any WHO failure. The global burden of disease project was limited by these issues, but it was undertaken as effectively in WHO as in any other organisation.
Not only are there problems in capacity, understanding the value of surveillance, and coverage of health services. The reporting of health events can be politically sensitive or even economically damaging. It is therefore likely that political interference will continue (whoever collects the data) until governments can be shown that honesty pays. It is perhaps this failure that needs to be dealt with rather than setting up yet another organisation without a proper analysis of the reasons (and locus) for failures in global health reporting. We refer to just three issues among many more.
WHO has mandate and expertise
Firstly, it is untrue that no affordable and feasible methods are currently available to assess tuberculosis in a community. China, India, and other countries have carried out a series of large scale population surveys of infection and disease that have shown, or have the potential to show, the impact of their tuberculosis control programmes. 2 3 Secondly, after years of exposure to these statistics, Murray et al still do not seem to understand the meaning of basic indicators, such as case detection, and how they are used in planning and evaluation. These indicators are fully explained in our annual report. 4 Thirdly, we reject absolutely the suggestion that WHO manipulates global tuberculosis statistics so as to advocate for the directly observed therapy, short course (DOTS) strategy, and fails to expose weaknesses in the data. With reference to Mozambique, the example chosen by Murray et al, our 2004 report clearly pointed out the strengths and weaknesses of the data.
WHO now routinely collects tuberculosis statistics from 200 countries, and the quality and diversity of the data on surveillance, planning, and financing are improving each year. We do not need another global health monitoring organisation that would dilute this effort and would do little to enable countries to use their data to correct their own problems. We need instead further international support for WHO and its established partners, which collectively have the mandate and expertise to carry out this work. 
Bottom up approach is more likely to be successful
Editor-Murray et al identify the need for better health information, but their solution is misguided. 1 How would their proposal for a richly funded "independent" organisation, primarily concerned with global monitoring be useful to countries?
Such top down, technocratic approaches emphasise global comparability at the expense of countries' ownership. Murray et al assume a priori that addressing the problems with global reporting will also fuel greater commitment among countries to strengthening national health information systems. This approach was used in the work of the World Health Organization that was led by Murray, on burden of disease, health system performance, and the world health survey. The results were an overemphasis on model building and global comparability, with tenuous links to empirical evidence and a notable absence of involvement from countries. WHO is now working to support the building of country information systems from the ground up while not neglecting its global monitoring role.
Bottom up approaches will not only generate data for country decision making but also produce the information needed by donors and international organisations for global monitoring. This is the underlying premise of the Health Metrics Network, a new global alliance aiming to increase the availability and use of sound data through the reform of country health information systems.
Examples abound of productive interaction between global monitoring and country information systems. Estimates of the Letters AIDS epidemic are generated by countries themselves using standardised methods. 2 3 In addition to empowering countries and stimulating the use of data for health action, this approach shows the importance of solid surveillance systems to countries. Capacity building in countries is therefore producing not only better country data but also better global monitoring. It would be wise to build on the current momentum of partnership and collaboration led by the Health Metrics Network and WHO. 
Cochrane Collaboration in developing world could be an answer
Editor-The need to develop and maintain a robust health information system that is free from political influence is undoubtedly important. The health promotion field of the Cochrane Collaboration has also recognised this need, identified priority areas of global importance, and is commissioning reviews. 1 The suggestion by Murray et al of an independent global organisation sounds similar to the ideals of the Cochrane Collaboration but seems to have a wider scope. 2 One of the problems with such organisations is that these centres are usually based in a developed country-for example, most centres of the Cochrane Collaboration are located in the developed world. An alternative to creating a new body looking at health information could be to help support establishing regional or national centres of a collaboration in the developing world; rather than to have yet another organisation based in a developed country. In my view, this is more likely to contribute to the development of a robust global health information system. Currently, country of birth has been included in each UK census since 1841 and is a readily available and objective, although crude, method of ethnic group classification. 2 Indeed it remains a good proxy for ethnic group for the older age minority groups and is of intrinsic interest in separating environmental and genetic differences. However, it is no longer an appropriate proxy as it does not take account of the diversity of the country of origin of the individual; the number of white people born in countries, such as India, ruled by the British Empire; and children of migrants identified by this method as second generation immigrants. In the 2001 census half of the minority ethnic population was born outside the United Kingdom.
Ilyas Mirza consultant psychiatrist
Further recording of country of birth on death certificates, which is reliant on an informant, may be less accurate than on the census, when the person is still alive to provide the information, leading to the possibility of numerator-denominator bias. Previous analyses of mortality by country of birth have grouped together countries for which this is a particular issue-South Asian countries 3 -but this approach obscures potentially important differences between countries of birth. 2 3 4 Despite these limitations, we have documented the marked variations in mortality by age, sex, and ethnic group. 5 This resource is available online and provides a wide range of data both on the morbidity and mortality by ethnic group that is of use for commissioning services for these minority communities. However, there is an urgent need to address the recording of ethnic group data on death certificates to accurately determine and address the health inequalities between ethnic groups in the United Kingdom. 
Specialised care for early psychosis
Like was not compared with like
Editor-Craig et al tried to evaluate early intervention services for psychosis empirically. 1 The results of the Lambeth Early Onset (LEO) trial may, however, be misrepresented, especially by those who think that early intervention services are a waste of valuable resources, 2 and be used to argue that resources should be directed to inadequately resourced routine services, the supposed comparison group in the LEO trial.
The comparison in the LEO trial was not between a well funded specialist team and run down inner city services, but between a newly formed specialist team that was learning on the job and between well established and integrated community mental health teams. A randomised controlled trial of a developing team at its inception is the equivalent of conducting a clinical trial on a drug without first establishing its pharmacokinetic and pharmacodynamic properties.
ETHOS, the neighbouring early intervention service in southwest London, was set up in July 2001. The ETHOS team has taken three years to determine the key ingredients of effective biological and psychosocial interventions for its patients, the appropriate generic and specialist skill mix of the team, the duration of service provision, pathways into and out of care, and strategies for preventing relapse. 
Letters
Despite all the problems entailed in developing and establishing a new service, the LEO trial shows some positive outcomes for patients receiving early intervention. It would be unfortunate therefore if the limited effectiveness of LEO intervention simply strengthens the prejudices of the nay-sayers and confirms the principle of dangerous precedent: nothing should ever be done for the first time. 
Swaran P Singh senior lecturer in mental health
More detail is needed
Editor-Craig et al evaluated the effectiveness of specialised care for early psychosis. 1 This is a good first step. What is different in the early intervention team work needs to be described more fully-for example, the frequency and regularity of appointments in assertive outreach and standard care.
People with schizophrenia benefit from a regimen that gives them something in the near future on which to anchor their inner thoughts, something to look forward to and reassemble "connecting" ability to outside expectation, rather than drifting. What is described is rather like a manifesto. Some idea of the numbers of people who were offered and took up cognitive behaviour therapy, vocational guidance, and particularly occupational activities that brought about "breaks" would be helpful. 
David H Yates retired psychiatrist
Author's reply
Editor-The Lambeth Early Onset (LEO) community team comprised experienced mental health professionals, most of whom had not previously worked in an early intervention service and were comparative novices at the interventions advocated by international experts. However, we contend that our pragmatic approach is precisely how many similar early intervention teams are being established, so that our results reflect the least that may be expected from these new services.
Although it may also have been better to have waited until the early intervention service was fully established, randomisation to non-specialist care would have been impossible to justify once the service had been running for two or three years-an observation that probably accounts for the dearth of relevant randomised controlled trials.
We will provide more detail on the process and outcomes of the LEO team later, but a few clarifications may be helpful. The work of the LEO community team differed from comparison sector teams mostly in terms of intensity. Patients in LEO were seen more frequently (an average of 13 visits in the first three months out of hospital compared with five for standard care).
Much of the effort was to help patients resume aspects of their life that had been disrupted by illness. Occupational and social activities were accorded as much importance as management of symptoms. Presumably as a result, LEO patients were more likely to continue drug treatment, with 50% still adherent at nine months compared with fewer than 30% in standard care. They spent twice as much of the follow up engaged in education or employment and had more satisfactory relationships with friends and family. Just over half of them took up offers of cognitive behaviour therapy for positive symptoms, and some family work was carried out in 40 LEO families, although this entailed mainly advice and support rather than formal therapy. Competing interests: TKJC has received support for attending seminars and fees for speaking at conferences on early psychosis from Eli Lilly, AstraZeneca, Janssen-Cilag, and Novartis.
Computer assisted knee arthroplasty is here today
Editor-Gidwani et al summarise the orthopaedic options for painful arthritis of the knee.
1 As they say, computer assisted surgery is not standard practice for most orthopaedic surgeons in the United Kingdom. Many cite a lack of long term follow up data for this technique to justify their reluctance to embrace this technology.
However, navigated arthroplasty surgery has been widely validated in the orthopaedic literature. 2 3 Lower limb mechanical alignment is one of the principal factors determining the survival of a total knee arthroplasty. As many as 10-15% of all knee prostheses ultimately require revision, many because of poor quality placement of the prosthetic components. 4 The failure rate of poorly aligned implants is more than twice that of well aligned implants. 5 The main reason for poor alignment arises from the difficulty of using anatomical reference points, and human judgment alone cannot ensure reproducible alignment. Mechanical alignment outcomes obtained using computer assisted surgery have consistently been superior to those obtained using traditional alignment methods. 2 3 Most data on survival of total knee arthroplasties originate from centres specialising in such surgery and therefore do not reflect the normal Gaussian spread of outcome obtained throughout the country.
Computer assisted arthroplasty narrows the spread of alignment and so improves the long term outcome of such surgery. Interestingly, few orthopaedic surgeons formally assess postoperative mechanical alignment by lower limb alignment films or computer tomography. Despite their inability to assess their outcomes, many would state that their technique does not require modification. We think this shows a lack of insight which must be addressed to maximise the survival of arthroplasties.
Preventing and treating hepatitis B infection
Immunisation is most important strategy to control hepatitis B Editor-The immunisation advice in the hepatitis B review by Aggarwal and Ranjan is potentially misleading. Firstly, recommending three doses at 0, 1, and 6 months is unnecessarily limiting; delaying the third dose can lead to lower compliance. Hepatitis B vaccine has been shown to be immunogenic when a wide range of schedules is used. 2 Although increasing the time between the second and third doses leads to higher antibody concentrations, it seems to be the immune memory rather than antibody concentrations that is of primary importance. A two dose schedule was approved for adolescents in the United States in 1999; it has also been suggested as being adequate for infants.
Secondly, the importance of hepatitis B immune globulin is overstated. It provides comparatively little additional protection to immunisation in preventing infection in infants of HBeAg positive mothers. 4 5 Thirdly, although recommending giving vaccine to infants of HBeAg positive mothers as soon as possible after birth is reasonable, the data are limited on the precise timing. A dose of hepatitis B vaccine given with immunisation leads to higher protection (70% to 95%) than if given after one week (50% to 57%), 2 w1-w3 but one study found protective efficacy of 75% for those who received vaccine alone in week two. w4 As the authors note, immunisation is the most important strategy in controlling hepatitis B.
